Cancer+

About the Journal

Editor-in-Chief: Dr Chong Li

ISSN: 2661-3840 (Online) 

          2661-3832 (Print) 

Publishing Frequency: Quarterly(four issues per year)

Article Processing Charges (APC): USD500

Publishing Model: Open Access

Collaborating InstitutionMedical Immunodiagnosis Research Center, Institute of Biophysics, Chinese Academy of Sciences

Cancer+ is a new research journal dedicated to the publication of findings in cancer research. This journal is a joint collaboration between Whioce Publishing Pte Ltd (Singapore) and the Chinese Academy of Sciences (China).

We encourage researchers to publish the latest findings in cancer research, including preliminary results, repeated argumentation studies and negative results. The journal welcomes various types of submissions e.g. research papers, clinical research reports, review articles, etc.

Cancer+ is indexed by CNKI and Google Scholar. Currently, Cancer+ is working towards being indexed by BIOSIS, Scopus, PubMed and Science Citation Index Expanded (SCIE)


Recent Articles

Research Articles

PDF
Zhengtai Li, Fusheng Li, Huixue Tang, Xiao Ge, Lida Xu, Changyuan Yu
64 Views, 17 PDF Downloads

Research Articles

PDF
Weina Wang, Chunlan Zhao, Yuemian Liang, Jinku Zhang
25 Views, 35 PDF Downloads

Research Articles

PDF
Thamaraiselvan Rengarajan, Sundararaj Keerthiga, Sivakumar Duraikannu, Velu Periyannan
37 Views, 13 PDF Downloads

Research Articles

PDF
Ruizhe Hao, Yaming Ji, Jinku Zhang, Bingjuan Zhou
36 Views, 14 PDF Downloads

Review Articles

PDF
Chong Li
65 Views, 32 PDF Downloads

Commentaries

PDF
Pingping Zhu
42 Views, 12 PDF Downloads

Announcements

 

Special Issue Call for Papers for Neoadjuvant therapy in the treatment of Breast Cancer

 

Background: In this special issue of Cancer + authors will analyze different approaches of the neoadjuvant treatment of HER2 positiveand/or hormone responsive and triple negative diseases as well as the general principles of neoadjuvant treatment.

 
Posted: 2020-01-08 More...
 
More Announcements...